Darrell Rigel - STRATA Skin Chief Advisor

SSKN Stock  USD 3.12  0.11  3.65%   

Insider

Darrell Rigel is Chief Advisor of STRATA Skin Sciences
Age 73
Address 5 Walnut Grove Drive, Horsham, PA, United States, 19044
Phone215 619 3200
Webhttps://www.strataskinsciences.com

STRATA Skin Management Efficiency

The company has return on total asset (ROA) of (0.0928) % which means that it has lost $0.0928 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7904) %, meaning that it created substantial loss on money invested by shareholders. STRATA Skin's management efficiency ratios could be used to measure how well STRATA Skin manages its routine affairs as well as how well it operates its assets and liabilities. As of the 10th of June 2024, Return On Tangible Assets is likely to drop to -0.4. In addition to that, Return On Capital Employed is likely to drop to -0.22. At this time, STRATA Skin's Intangibles To Total Assets are very stable compared to the past year. As of the 10th of June 2024, Debt To Assets is likely to grow to 0.38, while Total Assets are likely to drop about 30.1 M.
STRATA Skin Sciences currently holds 15.63 M in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. STRATA Skin Sciences has a current ratio of 1.27, suggesting that it may have difficulties to pay its financial obligations when due. Note, when we think about STRATA Skin's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 3 records

INSIDER Age

Danielle WatsonHeart Test Laboratories
41
Xavier MSbioAffinity Technologies Warran
54
Maria JDbioAffinity Technologies Warran
68
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Strata Skin operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 115 people. STRATA Skin Sciences (SSKN) is traded on NASDAQ Exchange in USA. It is located in 5 Walnut Grove Drive, Horsham, PA, United States, 19044 and employs 99 people. STRATA Skin is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

STRATA Skin Sciences Leadership Team

Elected by the shareholders, the STRATA Skin's board of directors comprises two types of representatives: STRATA Skin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STRATA. The board's role is to monitor STRATA Skin's management team and ensure that shareholders' interests are well served. STRATA Skin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, STRATA Skin's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dolev Rafaeli, CEO President
Shmuel Gov, Chief Officer
Robert Moccia, CEO Pres
William MBA, Ex Chairman
Michael Stewart, CEO and President and Director
Michael Goodman, Head Sales
Darrell Rigel, Chief Advisor
Keith Simeone, VP Sales
Nikolai Kabelev, VP RD
Christopher Lesovitz, Chief Officer
Jay Sturm, General Secretary

STRATA Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is STRATA Skin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in STRATA Stock

When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.30)
Revenue Per Share
9.307
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.09)
Return On Equity
(0.79)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.